Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Organic Letters|January 5, 2002
Reversible backbone protection enables combinatorial solid-phase ring-closing metathesis reaction (RCM) in peptidesNiko Schmiedeberg, Horst KesslerRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|June 7, 2003
The urokinase receptor (uPAR, CD87) as a target for tumor therapy: uPA-silica particles (SP-uPA) as a new tool for assessing synthetic peptides to interfere with uPA/uPA-receptor interactionElke Guthaus, Niko Schmiedeberg, Markus Bürgle, et al.Journal of Medicinal Chemistry|November 1, 2002
Synthesis, solution structure, and biological evaluation of urokinase type plasminogen activator (uPA)-derived receptor binding domain mimeticsNiko Schmiedeberg, Manfred Schmitt, Christian Rölz, et al.Angiogenesis|August 31, 2010
The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesisGeorg Martiny-Baron, Philipp Holzer, Eric Billy, et al.Biological Chemistry|April 5, 2002
uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeuticsElke Guthaus, Markus Bürgle, Niko Schmiedeberg, et al.Journal of Medicinal Chemistry|November 21, 2014
G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotypeKlemens Högenauer, Luca Arista, Niko Schmiedeberg, et al.The Journal of Biological Chemistry|April 29, 2015
The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain FoldSascha Gutmann, Alexandra Hinniger, Gabriele Fendrich, et al.ACS Medicinal Chemistry Letters|July 19, 2023
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation FieldAnna Vulpetti, Philipp Holzer, Niko Schmiedeberg, et al.Cell Reports|August 31, 2023
Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality controlLukas-Adrian Gurzeler, Marion Link, Yvonne Ibig, et al.Nature Communications|December 9, 2025
Fragment-based discovery enables direct targeting of the melanoma oncogene MITFDeborah Castelletti, Jürgen Hinrichs, Goran Malojčić, et al.Pageof 2